Post-Bariatric Patients See More Benefits With Semaglutide vs Liraglutide
(MedPage Today) -- SAN DIEGO -- A 1-mg dose of semaglutide (Wegovy) weekly was better at maintaining weight than 3-mg liraglutide (Saxenda) daily for patients who put on pounds after bariatric surgery, a retrospective study suggested. Among... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 3, 2022 Category: Endocrinology Source Type: news

Glucose-Lowering Meds Compared for Use With Metformin in T2DM
MONDAY, Oct. 3, 2022 -- For patients with type 2 diabetes receiving metformin, the addition of glargine and liraglutide is more effective than glimepiride and sitagliptin for achieving and maintaining target glycated hemoglobin levels, while the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 3, 2022 Category: Pharmaceuticals Source Type: news

GRADE Published: Liraglutide Best for Type 2 Diabetes After Metformin GRADE Published: Liraglutide Best for Type 2 Diabetes After Metformin
The US-funded GRADE trial shows liraglutide performed best overall when added to metformin, followed by insulin glargine, with sitagliptin and glimepiride trailing. But SGLT2 inhibitors were not included in study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 21, 2022 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

ICER Dumps on Wegovy Cost-Effectiveness; Kerendia Label Update; Synthetic Embryos?
(MedPage Today) -- The Institute for Clinical and Economic Review (ICER) said that while subcutaneous semaglutide (Wegovy) "is more effective, less burdensome, and more cost effective than liraglutide [Victoza]," it "does not meet typical cost... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 7, 2022 Category: Endocrinology Source Type: news

A Novel Treatment and Other Parkinson's Updates From AAN 2022 A Novel Treatment and Other Parkinson's Updates From AAN 2022
Dr Kathrin LaFaver and Dr Indu Subramanian discuss promising data with the GLP-1 agonist liraglutide, and other research on Parkinson ' s disease that caught their attention.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 17, 2022 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

Diabetes Drug for Bile Acid Diarrhea Bests Standard of Care in Small Trial
(MedPage Today) -- Glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide (Victoza, Saxenda) may be superior to colesevelam (Welchol) for reducing stool frequency in patients with moderate-to-severe bile acid diarrhea, a small randomized... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 21, 2022 Category: Gastroenterology Source Type: news

Exercise, Good Sleep Help Maintain Weight Loss in Obesity Exercise, Good Sleep Help Maintain Weight Loss in Obesity
Maintaining weight loss is improved by good sleep quality and exercise in people with obesity, while liraglutide has no effect.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - May 10, 2022 Category: Endocrinology Tags: Family Medicine/Primary Care News Source Type: news

Semaglutide Superior to Liraglutide for Weight Loss
FRIDAY, Jan. 21, 2022 -- Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 21, 2022 Category: Pharmaceuticals Source Type: news

Wegovy Tops Sibling Saxenda for Weight Loss Wegovy Tops Sibling Saxenda for Weight Loss
Semaglutide was the clear weight-loss winner compared with liraglutide, from the same drug class, when added to lifestyle counseling for people with overweight/obesity but not diabetes, a study shows.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 11, 2022 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

More STEP Data: Semaglutide Cuts Weight, Cravings, Beats Liraglutide More STEP Data: Semaglutide Cuts Weight, Cravings, Beats Liraglutide
In STEP 5, weight loss with semaglutide was sustained at 2 years and the drug cut cravings in a subgroup; in STEP 8, semaglutide beat liraglutide for weight loss at 68 weeks. There were no new safety signals.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 11, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Liraglutide Effective for Weight Regain After Gastric Bypass Liraglutide Effective for Weight Regain After Gastric Bypass
In a randomized controlled trial of patients who regained weight after a gastric bypass, 69% of patients given liraglutide lost at least 5% of their weight after a year; lifestyle advice alone did not work.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 5, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

FDA approves weight management drug for patients aged 12 and older
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 30, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Liraglutide Reduces Visceral Fat in Overweight, Obese Adults
WEDNESDAY, Aug. 25, 2021 -- For overweight and obese adults at high cardiovascular risk, liraglutide reduces visceral adipose tissue, according to a study published online Aug. 3 in The Lancet Diabetes& Endocrinology. Ian J. Neeland, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 25, 2021 Category: Pharmaceuticals Source Type: news

Is there any diet pill that can help you lose weight safely?
Saxenda (generic name, liraglutide) was originally developed as a drug for diabetes but has been shown to reduce body weight by, on average, 7.5 per cent in under nine months. (Source: the Mail online | Health)
Source: the Mail online | Health - July 12, 2021 Category: Consumer Health News Source Type: news

What's Best for Diabetes After Metformin? GRADE Outdated at Outset What's Best for Diabetes After Metformin? GRADE Outdated at Outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, and while liraglutide and insulin glargine fared best, the study is already outdated, said one commentator.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news